BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 26, 2003
View Archived Issues
Bayer presents novel VR1 antagonists for urinary incontinence, pain, etc.
Read More
New thrombolytic carboxypeptidase U inhibitors in early development at Merck
Read More
Sanofi-Synthelabo claims new inhibitors of Abeta production for AD and other disorders
Read More
New series of anticytomegalovirus agents covered by Bayer patent
Read More
Alphav integrin antagonists discovered by Merck KGaA researchers
Read More
GSK scientists identify new 5-HT6 receptor ligands for depression, anxiety and other uses
Read More
Potent and selective COX-2 inhibitors prepared and tested at GSK
Read More
Cathepsin K inhibitors and their use in osteoporosis reported by GSK
Read More
Virginia Commonwealth U. researchers design nonopioid and non-nicotinic analgesics
Read More
New antibacterial and antifungal MUC7-derived peptides
Read More
GTI-2040 awarded orphan drug status for renal cell cancer
Read More
Basulin shows comparable pharmacokinetic profile to Lantus in healthy volunteers
Read More
Allergan and ExonHit collaborate on drug discovery, development & commercialization
Read More
Elan and Ingenium to develop pain management therapeutics
Read More
Brigham Young University and Merck & Co. sign COX licensing agreement
Read More
New data on efalizumab in plaque psoriasis
Read More
Antithrombotic and antiinflammatory effects described for drotrecogin alfa (activated) in sepsis
Read More
Improvement of pain associated with major depression after duloxetine administration
Read More
Intrathecal ziconotide in pain
Read More
Good safety profile established for IDEC-152 in patients with seasonal allergic rhinitis
Read More
NIH licensing a class of gp100 cancer antigens
Read More
Novel cyclic polyamines that release NO in a biphasic manner available for licensing
Read More
Licenses offered for peptide inhibitors of Yersinia YopH as potential treatments for plague
Read More
FTC staff completes review of Pfizer-Pharmacia merger
Read More
Amendment to miglustat NDA submitted
Read More
Independent panel examines AZD-3582 trial protocol
Read More